INIS
animals
9%
antibodies
23%
antigens
15%
balances
8%
bladder
9%
bone marrow
13%
cancer
12%
chains
8%
comparative evaluations
15%
control
9%
conversion
10%
cytokines
12%
data
21%
death
36%
diseases
41%
doses
19%
expansion
11%
genes
9%
globulins
19%
grafts
37%
humans
23%
immunity
18%
in vivo
13%
induction
34%
inflammation
33%
injuries
12%
interleukins
13%
ischemia
13%
kidneys
26%
levels
8%
ligands
29%
mice
100%
molecules
23%
monoclonal antibodies
14%
organs
25%
pancreas
16%
patients
15%
production
14%
rabbits
13%
rats
10%
receptors
19%
regulations
26%
reviews
10%
rort
10%
signals
11%
therapy
30%
thymocytes
13%
tissues
10%
tolerance
85%
transplants
66%
Medicine and Dentistry
Abatacept
19%
Allograft
33%
Alloimmunity
17%
Antigen
11%
Aptitude
9%
Autoimmune Diabetes
21%
Autoimmune Disease
12%
Autoimmunity
39%
B Cell
11%
Bone Marrow
12%
Calcineurin Inhibitor
9%
Cardiac Allograft Vasculopathy
13%
Cardiac Graft Rejection
9%
Cells
37%
Chemokine Receptor
10%
Combination Therapy
26%
Cytotoxic T-Cell
15%
Death
14%
Development
16%
Diabetes
32%
Diabetes Mellitus
14%
Diseases
25%
Donor
29%
Exhaustion
16%
Globulin
9%
Graft Rejection
23%
Graft Survival
20%
Human
10%
Insulin Dependent Diabetes Mellitus
22%
Islet Transplantation
10%
Ligand
9%
Low Drug Dose
11%
Memory B Cell
12%
NOD Mice
29%
Organ Transplantation
11%
Pancreas
12%
Patient
10%
Programmed Death-Ligand 1
24%
Rapamycin
19%
Regulatory Mechanism
26%
Regulatory T Cell
21%
Serositis
17%
T Cell
68%
T-Helper Cell
26%
Tacrolimus
21%
Therapeutic Procedure
21%
Thymocyte
9%
Thymocyte Antibody
16%
Transplantation
60%
Transplantation Tolerance
16%
Immunology and Microbiology
Abatacept
14%
Allograft Vasculopathy
14%
Alloimmunity
9%
Allotransplantation
33%
Antigen
10%
Aptitude
9%
Autoimmune Diabetes
20%
Autoimmune Disease
13%
Autoimmunity
20%
B Cell
15%
Bone Marrow
12%
CD154
9%
CD160
12%
CD28
15%
CD4
35%
CD8
16%
Cells
36%
CXC Chemokine Receptors
10%
Development
22%
Electric Potential
9%
Everolimus
9%
Immune Response
12%
Immune Tolerance
9%
Immunity
15%
Immunity
12%
Inflammation
14%
Interleukin 17
9%
Intravenous Immunoglobulin
14%
Islet Transplantation
12%
Kidney
11%
Low Drug Dose
10%
Memory B Cell
12%
MHC Class II
13%
Molecule
22%
Monospecific Antibody
14%
Mouse
21%
Nonobese Diabetic Mouse
22%
Organ
15%
Programmed Death 1 Ligand 1
16%
Regulatory Mechanism
20%
Regulatory T Cell
51%
Sirolimus
15%
Survival
21%
T Cell Activation
22%
Tacrolimus
21%
Tolerance in Transplantation
10%
Transplant Rejection
24%
Transplantation
67%
Transplantation Tolerance
17%
Virus
12%